[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 81,341,504 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739%]
[Form 6-K TABLE OF CONTENTS Page 3 4 6]
[Form 6-K TABLE OF CONTENTS Page 3 4 6]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 PRESS RELEASE DATED August 2, 2010 2]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 PRESS RELEASE DATED August 2, 2010 2]
[SCHEDULE 13D/A CUSIP No. Page 2 of 14 pages 1 NAME OF REPORTING PERSONS Warburg Pincus Private Equity X, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) (b) ⊠]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Press Release dated July 29, 2010 99.1 Termination Agreement dated as of July 29, 2010 between WuXi PharmTech (Cayman) Inc. and Charles River Laboratories International, Inc. 99.2 WuXi PharmaTech (Cayman) Inc. E I]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Press Release dated July 29, 2010 99.1 Termination Agreement dated as of July 29, 2010 between WuXi PharmTech (Cayman) Inc. and Charles River Laboratories International, Inc. 99.2 WuXi PharmaTech (Cayman) Inc. E I]
